Thus, blood KL-6 is considered an indicator for pulmonary damage, and has been reported to be a useful biomarker for diagnosis and for estimating disease severity, acute exacerbation, and prognosis in ILD [20–22]. The gene discussed is MUC1; the disease is interstitial lung disease.